Lv3
304 积分 2023-10-21 加入
BP-lowering effects of SGLT-2 inhibitors and finerenone: an indirect comparison in patients with chronic kidney disease and type 2 diabetes
22天前
已完结
A Target Trial Emulation Study of SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Combination Therapy in Preventing Kidney Failure in Type 2 Diabetes
2个月前
已完结
Kidney and heart failure outcomes associated with SGLT2 inhibitor use
2个月前
已完结
GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes
2个月前
已完结
Effectiveness and safety of finerenone in non-diabetic patients with IgA nephropathy
4个月前
已完结
IgA Nephropathy
5个月前
已完结
Statins and kidney health: exploring cardiovascular benefits, renal protection, and risks in chronic kidney disease
7个月前
已完结
Antigens in membranous nephropathy: discovery and clinical implications
8个月前
已完结
Drug-Induced Membranous Nephropathy
8个月前
已完结
皖公网安备34019202002308
